http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24219006

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 181
issn 1465-3249
issueIdentifier 2
pageRange 173-181
publicationName Cytotherapy
startingPage 173
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_eacf2e9796c1d1813f9c33b5c86f03f4
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_90b0aa9495209ec6fa0e4ed842b2bce3
bibliographicCitation Poonia B, Pauza CD. Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity. Cytotherapy. 2012 Feb;14(2):173–81. doi: 10.3109/14653249.2011.623693. PMID: 22029653.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9640-0524
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd292e663a6492e44f1325c7ced369ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7098b0fd85e84dad688f6976eef12cc9
date 201202
identifier https://doi.org/10.3109/14653249.2011.623693
https://pubmed.ncbi.nlm.nih.gov/22029653
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27065
https://portal.issn.org/resource/ISSN/1465-3249
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity
discusses http://id.nlm.nih.gov/mesh/M0544979
http://id.nlm.nih.gov/mesh/M0011506
http://id.nlm.nih.gov/mesh/M0513695
http://id.nlm.nih.gov/mesh/M0025425
http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0028376
http://id.nlm.nih.gov/mesh/M0026482
http://id.nlm.nih.gov/mesh/M0045988
http://id.nlm.nih.gov/mesh/M0449318
http://id.nlm.nih.gov/mesh/M0015421
http://id.nlm.nih.gov/mesh/M0234600
http://id.nlm.nih.gov/mesh/M0006519
http://id.nlm.nih.gov/mesh/M0390307
http://id.nlm.nih.gov/mesh/M0446823
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D004164Q000494
http://id.nlm.nih.gov/mesh/D007093Q000494
http://id.nlm.nih.gov/mesh/D013601Q000276
http://id.nlm.nih.gov/mesh/D044966Q000494
http://id.nlm.nih.gov/mesh/D016692Q000276
http://id.nlm.nih.gov/mesh/D000920Q000276
http://id.nlm.nih.gov/mesh/D007376Q000276
http://id.nlm.nih.gov/mesh/D015658Q000276
hasSubjectTerm http://id.nlm.nih.gov/mesh/D016130
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D017452Q000378
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D017452Q000276
http://id.nlm.nih.gov/mesh/D019002Q000276
http://id.nlm.nih.gov/mesh/D009943Q000494
http://id.nlm.nih.gov/mesh/D045782Q000494
http://id.nlm.nih.gov/mesh/D058851Q000378
http://id.nlm.nih.gov/mesh/D008213Q000187
http://id.nlm.nih.gov/mesh/D058851Q000276
http://id.nlm.nih.gov/mesh/D007376Q000378
http://id.nlm.nih.gov/mesh/D015658Q000628
http://id.nlm.nih.gov/mesh/D000077211
http://id.nlm.nih.gov/mesh/D006678Q000276
http://id.nlm.nih.gov/mesh/D019002Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9a784dff46ed44d6c0b5f4ad7f906f62
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3ad2119464233024868ba3753ac34390
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2bd07a19b5756264ad211f430a592075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1195
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_375c17477d468e8296a40307695528e6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab9bc7ce433266ca5b4543e538aeed73
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0d1c0203c86182a45fb1c6272bbe1d33

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128755821

Total number of triples: 74.